Acadian Asset Management LLC Ac Immune Sa Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Ac Immune Sa stock. As of the latest transaction made, Acadian Asset Management LLC holds 46,012 shares of ACIU stock, worth $163,342. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,012

Holding current value

$163,342

% of portfolio

0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$2.99 - $4.2 $137,575 - $193,250	46,012 New	46,012 $172,000
Q1 2023 May 11, 2023	BUY	$2.13 - $2.49 $8,189 - $9,574	3,845 New	3,845 $8,000
Q4 2021 Feb 10, 2022	SELL	$4.83 - $7.56 $517,259 - $809,623	-107,093 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$6.2 - $8.34 $727,867 - $979,099	-117,398 Reduced 52.3%	107,093 $717,000
Q2 2021 Aug 11, 2021	SELL	$6.04 - $8.37 $313,651 - $434,645	-51,929 Reduced 18.79%	224,491 $1.78 Million
Q1 2021 May 11, 2021	SELL	$5.32 - $8.96 $2.05 Million - $3.46 Million	-386,092 Reduced 58.28%	276,420 $2.1 Million
Q4 2020 Feb 11, 2021	SELL	$4.47 - $5.58 $855,414 - $1.07 Million	-191,368 Reduced 22.41%	662,512 $3.43 Million
Q3 2020 Nov 09, 2020	BUY	$4.78 - $9.06 $405,477 - $768,541	84,828 Added 11.03%	853,880 $4.17 Million
Q2 2020 Aug 12, 2020	BUY	$6.57 - $8.3 $139,750 - $176,549	21,271 Added 2.84%	769,052 $5.18 Million
Q1 2020 May 11, 2020	BUY	$4.24 - $9.89 $1.81 Million - $4.22 Million	426,542 Added 132.78%	747,781 $5.16 Million
Q4 2019 Feb 06, 2020	BUY	$4.56 - $8.78 $791,410 - $1.52 Million	173,555 Added 117.52%	321,239 $2.74 Million
Q3 2019 Nov 07, 2019	BUY	$4.8 - $5.89 $284,116 - $348,634	59,191 Added 66.89%	147,684 $729,000
Q2 2019 Aug 08, 2019	BUY	$4.72 - $5.88 $417,686 - $520,338	88,493 New	88,493 $492,000

Others Institutions Holding ACIU

# of Institutions

Shares Held

28.2M

Call Options Held

150K

Put Options Held

12.4K

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $296M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Ac Immune Sa Transaction History